Zepp Health (ZEPP)
(Delayed Data from NYSE)
$3.49 USD
+0.18 (5.44%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $3.50 +0.01 (0.29%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZEPP 3.49 +0.18(5.44%)
Will ZEPP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ZEPP based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ZEPP
Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested
Amazfit Signs HYROX World Champion Athletes Meg Jacoby and Hunter McIntyre as Brand Ambassadors
Zepp Health plans to implement ADS ratio change
Zepp Health Corporation Announces Plan to Implement ADS Ratio Change
Zepp Health to change ratio of American depositary shares